While the capabilities of robots have improved significantly over the past decades, they are not always able to reliably and ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

For the last three years, the world has obsessed over generative AI that can write and create. By the end of 2026, we'll see ...